Literature DB >> 25353341

Phosphorylation of sterol regulatory element-binding protein (SREBP)-1c by p38 kinases, ERK and JNK influences lipid metabolism and the secretome of human liver cell line HepG2.

Birgit Knebel1, Stefan Lehr, Sonja Hartwig, Jutta Haas, Gernot Kaber, Hans-Dieter Dicken, Franciscus Susanto, Lothar Bohne, Sylvia Jacob, Ulrike Nitzgen, Waltraud Passlack, Dirk Muller-Wieland, Jorg Kotzka.   

Abstract

The transcription factor sterol regulatory element binding protein (SREBP)-1c plays a pivotal role in lipid metabolism. In this report we identified the main phosphorylation sites of MAPK-families, i.e. p38 stress-activated MAPK (p38), ERK-MAPK (ERK) or c-JUN N-terminal protein kinases (JNK) in SREBP-1c. The major phosphorylation sites of p38, i.e. serine 39 and threonine 402, are identical to those we recently identified in the splice-variant SREBP-1a. In contrast, ERK and JNK phosphorylate SREBP-1c at two major sites, i.e. threonine 81 and serine 93, instead of one site in SREBP-1a. Functional analyses of the biological outcome in the human liver cell line HepG2 reveals SREBP-1c phosphorylation dependent alteration in lipid metabolism and secretion pattern of lipid transporting proteins, e.g. ApoE or ApoA1. These results suggest that phosphorylation of SREBP-1c by different MAPKs interferes with lipid metabolism and the secretory activity of liver cells.

Entities:  

Keywords:  Dyslipidemia; NAFLD; fatty acids; hepatokine; secretome

Mesh:

Substances:

Year:  2014        PMID: 25353341     DOI: 10.3109/13813455.2014.973418

Source DB:  PubMed          Journal:  Arch Physiol Biochem        ISSN: 1381-3455            Impact factor:   4.076


  16 in total

Review 1.  Innate immune regulatory networks in hepatic lipid metabolism.

Authors:  Lan Bai; Hongliang Li
Journal:  J Mol Med (Berl)       Date:  2019-03-19       Impact factor: 4.599

Review 2.  JNK Signaling: Regulation and Functions Based on Complex Protein-Protein Partnerships.

Authors:  András Zeke; Mariya Misheva; Attila Reményi; Marie A Bogoyevitch
Journal:  Microbiol Mol Biol Rev       Date:  2016-07-27       Impact factor: 11.056

3.  Dietary flavones counteract phorbol 12-myristate 13-acetate-induced SREBP-2 processing in hepatic cells.

Authors:  Yan Qin Tan; Tsz Yan Wong; Shu-Mei Lin; Lai K Leung
Journal:  Mol Cell Biochem       Date:  2016-10-24       Impact factor: 3.396

4.  Metabolic Impact of MKP-2 Upregulation in Obesity Promotes Insulin Resistance and Fatty Liver Disease.

Authors:  Savanie Fernando; Jacob Sellers; Shauri Smith; Sarayu Bhogoju; Sadie Junkins; Morgan Welch; Orion Willoughby; Nabin Ghimire; Cassandra Secunda; Marina Barmanova; Sean C Kumer; Kisuk Min; Ahmed Lawan
Journal:  Nutrients       Date:  2022-06-15       Impact factor: 6.706

5.  Polychlorinated biphenyls disrupt hepatic epidermal growth factor receptor signaling.

Authors:  Josiah E Hardesty; Banrida Wahlang; K Cameron Falkner; Heather B Clair; Barbara J Clark; Brian P Ceresa; Russell A Prough; Matthew C Cave
Journal:  Xenobiotica       Date:  2017-06-21       Impact factor: 1.908

6.  SREBP1 regulates mitochondrial metabolism in oncogenic KRAS expressing NSCLC.

Authors:  Christian F Ruiz; Emily D Montal; John A Haley; Alex J Bott; John D Haley
Journal:  FASEB J       Date:  2020-06-22       Impact factor: 5.834

7.  MiR-27a-5p Increases Steer Fat Deposition Partly by Targeting Calcium-sensing Receptor (CASR).

Authors:  Wucai Yang; Keqiong Tang; Yaning Wang; Linsen Zan
Journal:  Sci Rep       Date:  2018-02-14       Impact factor: 4.379

8.  Hepatic Mitochondrial SAB Deletion or Knockdown Alleviates Diet-Induced Metabolic Syndrome, Steatohepatitis, and Hepatic Fibrosis.

Authors:  Sanda Win; Robert W M Min; Jun Zhang; Gary Kanel; Brad Wanken; Yibu Chen; Meng Li; Ying Wang; Ayako Suzuki; Filbert W M Aung; Susan F Murray; Mariam Aghajan; Tin A Than; Neil Kaplowitz
Journal:  Hepatology       Date:  2021-10-10       Impact factor: 17.425

9.  Long noncoding RNA MALAT1 promotes hepatic steatosis and insulin resistance by increasing nuclear SREBP-1c protein stability.

Authors:  Caifeng Yan; Jinfeng Chen; Nuoqi Chen
Journal:  Sci Rep       Date:  2016-03-03       Impact factor: 4.379

10.  Transgelin-2 is a novel target of KRAS-ERK signaling involved in the development of pancreatic cancer.

Authors:  Yan Sun; Wenfang Peng; Weiwei He; Man Luo; Guilin Chang; Jiping Shen; Xiaoping Zhao; Yu Hu
Journal:  J Exp Clin Cancer Res       Date:  2018-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.